Induction of T-cell response to cryptic MHC determinants during allograft rejection

被引:26
作者
Boisgérault, F
Anosova, NG
Tam, RC
Illigens, BMW
Fedoseyeva, EV
Benichou, G
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Cellular & Mol Immunol Lab, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02114 USA
[3] ICN Pharmaceut Inc, Costa Mesa, CA USA
关键词
MHC molecules; allotransplantation; T-cell response; tolerance; immunodominance;
D O I
10.1016/S0198-8859(00)00209-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The presentation of MHC peptides by recipient and donor antigen presenting cells is an essential element in allorecognition and allograft reject-ion. MHC proteins contains two sets of determinants: the dominant determinants that are efficiently processed and presented to T cells, and thr cryptic determinants that are not presented sufficiently enough to induce T-cell responses in vivo. In transplanted mice, initial T-cell response to MHC peptides is consistently limited to a single or a few immunodominant determinants on donor MHC molecule. However, in this article we show that under appropriate circumstances the hierarchy of determinants on MHC molecules can be disrupted. First, we observed that gamma IFN can trigger de novo presentation of cryptic self-MHC pep-tides by spleen cells. Moreover, we showed that allotransplantation is associated with induction of T-cell responses to formerly cryptic determinants on both syngeneic and allogeneic MHC molecules. Our results suggest thar cross-reactivity and inflammation are responsible for che initiation of these auto- and alloimmune responses after transplantation. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:1352 / 1362
页数:11
相关论文
共 54 条
[1]   PEPTIDE CONTRIBUTES TO THE SPECIFICITY OF POSITIVE SELECTION OF CD8+ T-CELLS IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
VANKAER, L ;
SCHUMACHER, TNM ;
PLOEGH, HL ;
TONEGAWA, S .
CELL, 1993, 73 (05) :1041-1049
[2]   EVIDENCE FOR A DIFFERENTIAL AVIDITY MODEL OF T-CELL SELECTION IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
BANDEIRA, A ;
DELANEY, JR ;
VANKAER, L ;
PIRCHER, HP ;
ZINKERNAGEL, RM ;
TONEGAWA, S .
CELL, 1994, 76 (04) :651-663
[3]  
ASHWELL JD, 1986, J IMMUNOL, V136, P389
[4]   THE ROLE OF INDIRECT RECOGNITION IN INITIATING REJECTION OF SKIN-GRAFTS FROM MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-DEFICIENT MICE [J].
AUCHINCLOSS, H ;
LEE, R ;
SHEA, S ;
MARKOWITZ, JS ;
GRUSBY, MJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3373-3377
[5]   BINDING OF IMMUNOGENIC PEPTIDES TO IA HISTOCOMPATIBILITY MOLECULES [J].
BABBITT, BP ;
ALLEN, PM ;
MATSUEDA, G ;
HABER, E ;
UNANUE, ER .
NATURE, 1985, 317 (6035) :359-361
[6]   INDIRECT T-CELL ALLORECOGNITION OF DONOR ANTIGENS CONTRIBUTES TO THE REJECTION OF VASCULARIZED KIDNEY ALLOGRAFTS [J].
BENHAM, AM ;
SAWYER, GJ ;
FABRE, JW .
TRANSPLANTATION, 1995, 59 (07) :1028-1032
[7]  
BENICHOU G, 1994, J IMMUNOL, V153, P938
[8]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[9]   IMMUNOGENICITY AND TOLEROGENICITY OF SELF-MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES [J].
BENICHOU, G ;
TAKIZAWA, PA ;
HO, PT ;
KILLION, CC ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1341-1346
[10]   Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation [J].
Benichou, G ;
Tam, RC ;
Soares, LRB ;
Fedoseyeva, EV .
IMMUNOLOGY TODAY, 1997, 18 (02) :67-71